CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 67  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1119
LYS 10.0338
GLU 20.1119
LEU 30.0455
ARG 40.0214
CYS 50.0231
GLN 60.0226
CYS 70.0164
ILE 80.0323
LYS 90.0386
THR 100.0064
TYR 110.0108
SER 120.0235
LYS 130.0199
PRO 140.0136
PHE 150.0064
HIS 160.0134
PRO 170.0196
LYS 180.0169
PHE 190.0069
ILE 200.0033
LYS 210.0190
GLU 220.0242
LEU 230.0166
ARG 240.0255
VAL 250.0114
ILE 260.0142
GLU 270.0536
SER 280.0481
GLY 290.0269
PRO 300.0488
HIS 310.0359
CYS 320.0241
ALA 330.0116
ASN 340.0113
THR 350.0241
GLU 360.0106
ILE 370.0104
ILE 380.0230
VAL 390.0136
LYS 400.0136
LEU 410.0052
SER 420.0046
ASP 430.0240
GLY 440.0095
ARG 450.0119
GLU 460.0186
LEU 470.0111
CYS 480.0129
LEU 490.0058
ASP 500.0136
PRO 510.0180
LYS 520.0250
GLU 530.0116
ASN 540.0122
TRP 550.0196
VAL 560.0184
GLN 570.0274
ARG 580.0203
VAL 590.0198
VAL 600.0235
GLU 610.0176
LYS 620.0137
PHE 630.0084
LEU 640.0090
LYS 650.0134
ARG 660.0123
ALA 670.0190
GLU 680.0338
ASN 690.0361

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.